Association between GSTM1 genetic polymorphism and lung cancer risk by SYBR green I real-time PCR assay

Chinese Journal of Lung Cancer

Volumn 13, Issue 5, 2010, Pages 506-510

  Zheng, Dejie ^a   Hua, Feng ^a   Mei, Chaorong ^a   Wan, Haisu ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphism; GSTM1 SYBR green I; Lung neoplasms

Indexed keywords

FLUORESCENT DYE; SYBR GREEN I; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GSTM1 GENE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELTING POINT; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ADULT; AGED; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANIC CHEMICALS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK;

EID: 77952832988     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.05.23     Document Type: Article

References (17)

1. Zou XN. Epidemiology of lung cancer in China. Chin J Cancer Prev Treatment, 2007,14(12): 881-883.
2. Li DR, Zhou QH. Advance in studies on genetic susceptibility of lung cancer. Chin J Lung Cancer, 2003, 6(2): 158-162.
3. Stücker I, Hirvoven A, Waziers I, et al. Genetic polymorphism of glutathione S-transferase as modulators of lung cancer susceptibility. Carcinogenesis, 2002, 23(9): 1475-1481. (Pubitemid 35012427)
4. Li DR, Zhou QH, Yuan TZ, et al. Study on the association between genetic polymorphism of CYP2E1, GSTM1 and susceptibility of lung cancer. Chin J Lung Cancer, 2005, 8(1): 14-19.
5. Ponchel F, Toomes C, Bransfiels K, et al. Real-time PCR based on SYBR-Green I fluorescence: An alternative to the Taqman assay for a relative quantification of gene rearrangements, gene amplications and micro gene deletions. BMC Biotechnol, 2003, 3(18): 1-13.
6. Shields P. Molecular epidemiology of smoking and lung cancer. Oncogene, 2002, 21(45): 6870-6876.
7. Tiwawech D, Chindavijak S, Karalak A, et al. Real-time PCR assay for rapid detection of GSTM1 polymorphism in nasopharyngeal carcinoma patients. Asian Pacific J Cancer Prev, 2008, 9(2): 233-238.
8. Li YR, Hu LH, Chen FH, et al. Rapid genotyping of HLA-B27 in Chinese Han population by SYBR Green I real-time PCR. J Clin Hematol, 2008, 21(10): 520-529.
9. Lei FM, Li SF, Zhou WD, et al. A case control study of the impact of glutathione S-transferase M1 polymorphism on the risk of lung cancer. Mod Prev Med, 2007, 34(4): 724-726.
10. Pan XH, Zhong WJ, Xiao P, et al. Study on relationship between smokers' CYP1A1 and GSTM1 gene polymorphism and DNA damage. J Environ Ocuup Med, 2006, 23(3): 211-242.
11. Wu XF, Zhao H, Suk R, et al. Genetic susceptibility to tobacco-related cancer. Oncogene, 2004, 23(38): 6500-6523.
12. Schwartze AG, Prysak GM, Bock CH, et al. The molecular epidemiology of lung cancer. Carcinogenesis, 2007, 28(3): 507-518.
13. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects glutathione S-transferase M1 polymorphism and smoking on lung cancer risk. Carcinogenesis, 2002, 23(8): 1343-1350.
14. Su YH, Wang XL, Xu SQ. The polymorphism of CYP1A1 and GSTM1 genes on individual susceptibility to lung cancer: Meta-analysis. Cancer Res Prev Treat, 2006, 33(5): 324-327.
15. Qian BY, Han HW, Gu f, et al. Case control study genetic polymorphism in CYP1A1 and GSTM1 and smoking and susceptibility to lung cancer. Chin J Clin Oncol, 2006, 33(9): 500-501.
16. Zeng M, Chen SD, Xie CM, et al. Case control study on relationship between lung cancer and it's susceptibility marker. Chin J Public Health, 2005, 21(7): 771-774.
17. Lee KM, Kang D, Clapper ML, et al. CYP1A1, GSTM1, and GSTP1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev, 2008, 17(5): 1120-1126.